Why Brown-Forman’s latest earnings have refocused attention on the stock

Brown-Forman (BF.B) is back in the spotlight after a mixed fourth quarter, with sales ahead of expectations but profitability under pressure, paired with cautious guidance for fiscal 2027 and a fresh analyst upgrade.

The share price has moved unevenly, with a 7.18% 7 day share price return and a 10.36% 90 day share price return. However, a 5 year total shareholder return that has declined 60.67% indicates that longer term momentum has faded.

If this earnings update has you reassessing your portfolio, it can help to contrast Brown-Forman with other opportunities and see what stands out in a different corner of the market, starting with 20 top founder-led companies

With Brown-Forman trading close to analyst targets yet flagged as trading below some estimates of intrinsic value, the key question is whether recent earnings weakness has created a genuine entry point, or if the market already reflects future growth.

Most Popular Narrative: 27.3% Overvalued

Brown-Forman’s most followed valuation narrative pegs fair value at about $21.00, compared with a last close of $26.73. It frames the gap through cautious growth and margin assumptions using a 6.98% discount rate.

The bearish analysts are assuming Brown-Forman's revenue will remain fairly flat over the next 3 years. The bearish analysts assume that profit margins will shrink from 20.6% today to 18.5% in 3 years time.

Want to see what keeps this fair value well below the current price? The narrative leans heavily on muted revenue progress, softer profitability, and a lower future earnings multiple. The exact mix of these inputs is where the story gets interesting.

Result: Fair Value of $21.00 (OVERVALUED)

However, if premium spirits keep gaining traction and Brown-Forman’s emerging market push builds on recent progress in Brazil and Mexico, this cautious narrative could quickly look too harsh.

Another View: What The P/E Ratio Is Telling You

The narrative describes Brown-Forman as about 27.3% overvalued at a $21.00 fair value. However, the current 17.1x P/E appears to represent good value versus peers at 42.1x and sits close to a 17.7x fair ratio, even though it is slightly expensive compared with the 16.8x global beverage average. So is sentiment too pessimistic, or are peers simply too richly priced?

Next Steps

Given the mixed signals around value and earnings, the real question is what you make of Brown-Forman’s risk and reward balance. To move quickly from headline impressions to your own judgment, start by weighing the 3 key rewards and 1 important warning sign

Looking for more investment ideas?

If Brown-Forman has sharpened your thinking, do not stop here. Use the screener to quickly surface other stocks that might deserve a closer look.

• Target income potential by reviewing companies that currently screen as 9 dividend fortresses with an eye on yield and resilience.
• Spot possible value opportunities by scanning 46 high quality undervalued stocks that combine quality metrics with pricing that may look appealing.
• Prioritize capital preservation by focusing on 63 resilient stocks with low risk scores that score well on financial strength and volatility checks.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.